ArticleFrontiers in immunology2025

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study.

Qi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.